Futura Medical (GB:FUM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Futura Medical PLC, the healthcare company focused on sexual health products, has awarded 2,176,000 share options to its employees and directors, with 905,000 of these granted to top executives. These options are exercisable between April 2027 and March 2034 at a price of 35.50p, contingent upon achieving certain performance milestones. The move aligns with the company’s long-term incentive plans and highlights its commitment to its lead product, Eroxon, a topical gel for erectile dysfunction.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.